Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality Measures

References

• Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019;43(3):123–131. doi:10.1053/j.semperi.2019.01.001
   PubMed Web of Science ®Google Scholar
• Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. doi:10.1136/bmj.j1550
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: a broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110(2):244–250. doi:10.2105/AJPH.2019.305412
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services; 2020. Administration. Available from: https://www.samhsa.gov/data/. Accessed May 27, 2021.
   Google Scholar
• Lewis CC, Boyd M, Puspitasari A, et al. Implementing measurement-based care in behavioral health: a review. JAMA Psychiatry. 2019;76(3):324–335. doi:10.1001/jamapsychiatry.2018.3329
   PubMed Web of Science ®Google Scholar
• Marsden J, Tai B, Ali R, Hu L, Rush AJ, Volkow N. Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective? Addiction. 2019;114(8):1346–1353. doi:10.1111/add.14546
   PubMed Web of Science ®Google Scholar
• Scott K, Lewis CC. Using measurement-based care to enhance any treatment. Cogn Behav Pract. 2015;22(1):49–59. doi:10.1016/j.cbpra.2014.01.010
   PubMed Web of Science ®Google Scholar
• Fortney JC, Unützer J, Wrenn G, et al. A tipping point for measurement-based care. Psychiatr Serv. 2017;68(2):179–188. doi:10.1176/appi.ps.201500439
   PubMed Web of Science ®Google Scholar
• Shatterproof National Principles of Care. Shatterproof website; 2020. Available from: https://www.shatterproof.org/shatterproof-national-principles-care. Accessed October 2, 2020.
   Google Scholar
• NIDA. Principles of effective treatment. National Institute on Drug Abuse website; 2020. Available from: https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition/principles-effective-treatment. Accessed October 2, 2020.
   Google Scholar
• Simon KM, Harris SK, Shrier LA, Bukstein OG. Measurement-based care in the treatment of adolescents with substance use disorders. Child Adolesc Psychiatr Clin N Am. 2020;29(4):675–690. doi:10.1016/j.chc.2020.06.006
   PubMed Web of Science ®Google Scholar
• Goodman JD, McKay JR, DePhilippis D. Progress monitoring in mental health and addiction treatment: a means of improving care. Prof Psychol Res Pr. 2013;44(4):231–246. doi:10.1037/a0032605
   Web of Science ®Google Scholar
• Stewart RE, Lareef I, Hadley TR, Mandell DS. Can we pay for performance in behavioral health care? Psychiatr Serv. 2017;68(2):109–111. doi:10.1176/appi.ps.201600475
   Web of Science ®Google Scholar
• O’Grady MA, Lincourt P, Gilmer E, et al. How are substance use disorder treatment programs adjusting to value-based payment? A statewide qualitative study. Subst Abuse. 2020;14:1178221820924026. doi:10.1177/1178221820924026
   Web of Science ®Google Scholar
• Schwartz RP, Gibson D, Pagano A, et al. An addiction medicine practice-based research network (AMNet): building partnerships. Psychiatr Serv. 2020.
   Web of Science ®Google Scholar
• American Psychiatric Association. PsychPRO: APA’s mental health registry website; 2020. Available from: https://www.psychiatry.org/psychiatrists/registry. Accessed October 2, 2020.
   Google Scholar
• US Food and Drug Administration. Opioid use disorder: endpoints for demonstrating effectiveness of drugs for medication-assisted treatment guidance for industry. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); 2020. Available from: https://www.fda.gov/media/114948/download. Accessed May 27, 2021.
   Google Scholar
• PROMIS. Healthmeasures website; 2020. Available from: http://www.healthmeasures.net/explore-measurement-systems/promis. Accessed October 22, 2020.
   Google Scholar
• PhenX website. PhenX consensus measures for phenotypes and exposures; 2020. Available from: https://www.phenx.org/. Accessed October 22, 2020.
   Google Scholar
• Ghitza UE, Gore-Langton RE, Lindblad R, Tai B. NIDA clinical trials network common data elements initiative: advancing big-data addictive-disorders research. Front Psychiatry. 2015;6:33. doi:10.3389/fpsyt.2015.00033
   PubMed Web of Science ®Google Scholar
• NIDA CTN Common Data Elements. National institute on drug abuse website; 2020. Available from: https://cde.drugabuse.gov/. Accessed October 22, 2020.
   Google Scholar
• Cacciola JS, Alterman AI, Dephilippis D, et al. Development and initial evaluation of the Brief Addiction Monitor (BAM). J Subst Abuse Treat. 2013;44(3):256–263. doi:10.1016/j.jsat.2012.07.013
   PubMed Web of Science ®Google Scholar
• Group W; Whoqol Group. Development of the WHOQOL: rationale and current status. Int J Ment Health. 1994;23(3):24–56. doi:10.1080/00207411.1994.11449286
   Web of Science ®Google Scholar
• Vilsaint CL, Kelly JF, Bergman BG, Groshkova T, Best D, White W. Development and validation of a Brief Assessment of Recovery Capital (BARC-10) for alcohol and drug use disorder. Drug Alcohol Depend. 2017;177:71–76. doi:10.1016/j.drugalcdep.2017.03.022
   PubMed Web of Science ®Google Scholar
• Ling W, Nadipelli VR, Solem CT, et al. Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the treatment effectiveness assessment. Subst Abuse Rehabil. 2019;10:13–21. doi:10.2147/SAR.S198361
   PubMed Web of Science ®Google Scholar
• Dragisic T, Dickov A, Dickov V, Mijatovic V. Drug addiction as risk for suicide attempts. Mater Sociomed. 2015;27(3):188–191. doi:10.5455/msm.2015.27.188-191
   PubMedGoogle Scholar
• Rizk MM, Herzog S, Dugad S, et al. Suicide risk and addiction: the impact of alcohol and opioid use disorders. Curr Addict Rep. 2021. doi:10.1007/s40429-021-00361-z
   Google Scholar
• Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–1277. doi:10.1176/appi.ajp.2011.10111704
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35(1):108–112. doi:10.1111/jrh.12307
   PubMed Web of Science ®Google Scholar
• Timko C, Schultz NR, Cucciare MA, Vittorio L, Garrison-Diehn C. Retention in medication-assisted treatment for opiate dependence: a systematic review. J Addict Dis. 2016;35(1):22–35. doi:10.1080/10550887.2016.1100960
   PubMed Web of Science ®Google Scholar
• Sullivan MA, Bisaga A, Pavlicova M, et al. A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder. Am J Psychiatry. 2019;176(2):129–137. doi:10.1176/appi.ajp.2018.17070732
   PubMed Web of Science ®Google Scholar
• National Quality Forum website; 2019. Available from: https://www.qualityforum.org/about_nqf/. Accessed October 28, 2019.
   Google Scholar
• Agency for Healthcare Research and Quality website; 2020. Available from: https://www.ahrq.gov/. Accessed October 22, 2020.
   Google Scholar
• National Committee for Quality Assurance website; 2020. Available from: https://www.ncqa.org/. Accessed October 22, 2020.
   Google Scholar
• Agency for Healthcare Research and Quality. Major Physician Measurement Sets.Updated September 2019. Available from: https://www.ahrq.gov/talkingquality/measures/setting/physician/measurement-sets.html. Accessed June 2, 2021.
   Google Scholar
• Center for Care Innovations website; 2020. Available from: https://www.careinnovations.org/. Accessed October 22, 2020.
   Google Scholar
• Harris AH, Weisner CM, Chalk M, Capoccia V, Chen C, Thomas CP. Specifying and pilot testing quality measures for the American Society of Addiction Medicine’s standards of care. J Addict Med. 2016;10(3):148–155. doi:10.1097/ADM.0000000000000203
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Bisaga A, et al. Developing an opioid use disorder treatment cascade: a review of quality measures [published correction appears in J Subst Abuse Treat. 2018 Sep;92:99]. J Subst Abuse Treat. 2018;91:57–68. doi:10.1016/j.jsat.2018.06.001
   PubMed Web of Science ®Google Scholar
• Mathematica Policy Research website; 2020. Available from: https://www.mathematica.org/. Accessed October 22, 2020.
   Google Scholar
• Pharmacy Quality Alliance website; 2020. Available from: https://www.pqaalliance.org/opioid-measure-endorsed. Accessed October 22, 2020.
   Google Scholar
• Pincus HA, Scholle SH, Spaeth-Rublee B, Hepner KA, Brown J. Quality measures for mental health and substance use: gaps, opportunities, and challenges. Health Aff (Millwood). 2016;35(6):1000–1008. doi:10.1377/hlthaff.2016.0027
   PubMed Web of Science ®Google Scholar
• Wray LO, Ritchie MJ, Oslin DW, Beehler GP. Enhancing implementation of measurement-based mental health care in primary care: a mixed-methods randomized effectiveness evaluation of implementation facilitation. BMC Health Serv Res. 2018;18(1):753. doi:10.1186/s12913-018-3493-z
   PubMed Web of Science ®Google Scholar
• Hsin H, Fromer M, Peterson B, et al. Transforming psychiatry into data-driven medicine with digital measurement tools. NPJ Digital Med. 2018;1(1):1–4. doi:10.1038/s41746-018-0046-0
   Web of Science ®Google Scholar
• Chan B, Gean E, Arkhipova-Jenkins I, et al. Retention strategies for medications for opioid use disorder in adults: a rapid evidence review [published online ahead of print, 2020 Sep 17]. J Addict Med. 2020. doi:10.1097/ADM.0000000000000739
   Web of Science ®Google Scholar
• Graff FS, Morgan TJ, Epstein EE, et al. Engagement and retention in outpatient alcoholism treatment for women. Am J Addict. 2009;18(4):277–288. doi:10.1080/10550490902925540
   PubMed Web of Science ®Google Scholar
• Cantone RE, Garvey B, O’Neill A, et al. Predictors of medication-assisted treatment initiation for opioid use disorder in an interdisciplinary primary care model. J Am Board Fam Med. 2019;32(5):724–731. doi:10.3122/jabfm.2019.05.190012
   Web of Science ®Google Scholar
• Winhusen T, Walley A, Fanucchi LC, et al. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): evidence-based practices in the HEALing communities study. Drug Alcohol Depend. 2020;217:108325. doi:10.1016/j.drugalcdep.2020.108325
   PubMed Web of Science ®Google Scholar
• Rosa C, Ghitza U, Tai B. Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience. Subst Abuse Rehabil. 2012;3(1):81–89. doi:10.2147/SAR.S31836
   Google Scholar
• McNeely J, Wu LT, Subramaniam G, et al. Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690–699. doi:10.7326/M16-0317
   PubMed Web of Science ®Google Scholar
• PhenX Toolkit website. Protocol-cigarette smoking status-adult; 2020. Available from: https://www.phenxtoolkit.org/protocols/view/30604. Accessed October 22, 2020.
   Google Scholar
• PhenX Toolkit website. Protocol-injection drug use; 2020. Available from: https://www.phenxtoolkit.org/protocols/view/161101. Accessed October 22, 2020.
   Google Scholar
• Gossop M. The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav. 1990;15(5):487–490. doi:10.1016/0306-4603(90)90036-w
   PubMed Web of Science ®Google Scholar
• Vernon MK, Reinders S, Mannix S, Gullo K, Gorodetzky CW, Clinch T. Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification. Addict Behav. 2016;60:109–116. doi:10.1016/j.addbeh.2016.03.028
   PubMed Web of Science ®Google Scholar
• Kleykamp BA, De Santis M, Dworkin RH, et al. Craving and opioid use disorder: a scoping review. Drug Alcohol Depend. 2019;205:107639. doi:10.1016/j.drugalcdep.2019.107639
   PubMed Web of Science ®Google Scholar
• Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010;8(4):348–353. doi:10.1370/afm.1139
   PubMed Web of Science ®Google Scholar
• Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35(2):253–259. doi:10.1080/02791072.2003.10400007
   PubMed Web of Science ®Google Scholar
• Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend. 2009;105(1–2):154–159. doi:10.1016/j.drugalcdep.2009.07.001
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150(1):173–182. doi:10.1016/j.pain.2010.04.025
   PubMed Web of Science ®Google Scholar
• Hadlandsmyth K, Dindo LN, St Marie BJ, et al. Patient-Reported Outcomes Measurement Information System (PROMIS) instruments: reliability and validity in veterans following orthopedic surgery. Eval Health Prof. 2020;43(4):207–212. doi:10.1177/0163278719856406
   Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research [published correction appears in J Chiropr Med. 2017 Dec;16(4):346]. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012
   PubMed Web of Science ®Google Scholar
• Statistics How to Website. Cronbach’s alpha: simple definition, use and interpretation; 2021. Available from: https://www.statisticshowto.com/wpcontent/uploads/2014/12/CA2.png. Accessed May 6, 2021.
   Google Scholar
• Statistics How to Website. Correlation coefficient: simple definition, formula, easy steps; 2021. Available from: https://www.statisticshowto.com/probability-and-statistics/correlation-coefficient-formula/#:~:text=Pearson’s%20Correlation%20Coefficient%20is%20a,is%20also%20called%20zero%20correlation. Accessed May 6, 2021.
   Google Scholar
• Department of Health and Human Services et al. Federal Policy for the Protection of Human Subjects. Final rule.Federal register the Daily Journal of the United States Government 2021;82(12):7149–7274. Available from: https://www.federalregister.gov/documents/2017/01/19/2017-01058/federal-policy-for-the-protection-of-human-subjects.
   Google Scholar